Logo image of SOPH

SOPHIA GENETICS SA (SOPH) Stock Analyst Ratings

USA - NASDAQ:SOPH - CH1125843347 - Common Stock

4.54 USD
+0.45 (+11%)
Last: 10/29/2025, 6:01:49 PM
4.44 USD
-0.1 (-2.2%)
After Hours: 10/29/2025, 6:01:49 PM
Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to SOPH. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 7.14. This target is 57.27% above the current price.
SOPH was analyzed by 10 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about SOPH.
In the previous month the buy percentage consensus was at a similar level.
SOPH was analyzed by 10 analysts. More opinions would make the average more meaningful.

Related screens

SOPH Historical Analyst RatingsSOPH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -49 -44 -39 -34 -29 -24 -19 -14 -9 -4 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 4.546.066.127.149.45 - 33.48% 34.80% 57.27% 108.15%

Related screens

SOPH Current Analyst RatingSOPH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2024-12-18 Craig-Hallum Initiate Buy
2024-08-07 RBC Capital Maintains Outperform -> Outperform
2024-06-27 Guggenheim Initiate Buy
2024-03-06 BTIG Maintains Buy -> Buy
2024-03-06 RBC Capital Reiterate Outperform -> Outperform
2024-01-12 RBC Capital Reiterate Outperform -> Outperform
2023-11-29 RBC Capital Initiate Outperform
2023-05-10 Credit Suisse Maintains Neutral
2023-05-10 Morgan Stanley Maintains Overweight
2023-03-08 Morgan Stanley Maintains Overweight
2023-01-03 BTIG Initiate Buy
2022-11-23 Credit Suisse Initiate Neutral
2022-11-09 Morgan Stanley Maintains Overweight
2022-08-10 Morgan Stanley Maintains Overweight
2022-05-11 Morgan Stanley Maintains Overweight
2022-02-15 Morgan Stanley Maintains Overweight
2021-08-17 Cowen & Co. Initiate Outperform
2021-08-17 JP Morgan Initiate Overweight
2021-08-17 Credit Suisse Initiate Outperform
2021-08-17 Morgan Stanley Initiate Overweight

SOPHIA GENETICS SA / SOPH FAQ

What is the price target for SOPH stock?

10 analysts have analysed SOPH and the average price target is 7.14 USD. This implies a price increase of 57.27% is expected in the next year compared to the current price of 4.54.


What is the consensus rating for SOPH stock?

The consensus rating for SOPHIA GENETICS SA (SOPH) is 86 / 100 . This indicates that analysts generally have a positive outlook on the stock.